Literature DB >> 31728578

Molecular mechanisms of topoisomerase 2 DNA-protein crosslink resolution.

Amanda A Riccio1, Matthew J Schellenberg1, R Scott Williams2.   

Abstract

The compaction of DNA and the continuous action of DNA transactions, including transcription and DNA replication, create complex DNA topologies that require Type IIA Topoisomerases, which resolve DNA topological strain and control genome dynamics. The human TOP2 enzymes catalyze their reactions via formation of a reversible covalent enzyme DNA-protein crosslink, the TOP2 cleavage complex (TOP2cc). Spurious interactions of TOP2 with DNA damage, environmental toxicants and chemotherapeutic "poisons" perturbs the TOP2 reaction cycle, leading to an accumulation of DNA-protein crosslinks, and ultimately, genomic instability and cell death. Emerging evidence shows that TOP2-DNA protein crosslink (DPC) repair entails multiple strand break repair activities, such as removal of the poisoned TOP2 protein and rejoining of the DNA ends through homologous recombination (HR) or non-homologous end joining (NHEJ). Herein, we discuss the molecular mechanisms of TOP2-DPC resolution, with specific emphasis on the recently uncovered ZATTZnf451-licensed TDP2-catalyzed TOP2-DPC reversal mechanism.

Entities:  

Keywords:  Chemotherapeutics; DNA strand breaks; Structural biology; TOP2; Tdp2; Topoisomerase 2; Tyrosyl DNA phosphodiesterase 2; ZATT; ZNF451

Mesh:

Substances:

Year:  2019        PMID: 31728578      PMCID: PMC6960353          DOI: 10.1007/s00018-019-03367-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  94 in total

1.  TDP2 protects transcription from abortive topoisomerase activity and is required for normal neural function.

Authors:  Fernando Gómez-Herreros; Janneke H M Schuurs-Hoeijmakers; Mark McCormack; Marie T Greally; Stuart Rulten; Rocío Romero-Granados; Timothy J Counihan; Elijah Chaila; Judith Conroy; Sean Ennis; Norman Delanty; Felipe Cortés-Ledesma; Arjan P M de Brouwer; Gianpiero L Cavalleri; Sherif F El-Khamisy; Bert B A de Vries; Keith W Caldecott
Journal:  Nat Genet       Date:  2014-03-23       Impact factor: 38.330

2.  Conjugation of human topoisomerase 2 alpha with small ubiquitin-like modifiers 2/3 in response to topoisomerase inhibitors: cell cycle stage and chromosome domain specificity.

Authors:  Marta Agostinho; Vera Santos; Fernando Ferreira; Rafael Costa; Joana Cardoso; Inês Pinheiro; José Rino; Ellis Jaffray; Ronald T Hay; João Ferreira
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

3.  A DNA-dependent protease involved in DNA-protein crosslink repair.

Authors:  Julian Stingele; Michael S Schwarz; Nicolas Bloemeke; Peter G Wolf; Stefan Jentsch
Journal:  Cell       Date:  2014-07-03       Impact factor: 41.582

4.  Synthesis and structure-activity relationship of furoquinolinediones as inhibitors of Tyrosyl-DNA phosphodiesterase 2 (TDP2).

Authors:  Le-Mao Yu; Zhu Hu; Yu Chen; Azhar Ravji; Sophia Lopez; Caroline B Plescia; Qian Yu; Hui Yang; Monica Abdelmalak; Sourav Saha; Keli Agama; Evgeny Kiselev; Christophe Marchand; Yves Pommier; Lin-Kun An
Journal:  Eur J Med Chem       Date:  2018-04-12       Impact factor: 6.514

Review 5.  Etoposide, topoisomerase II and cancer.

Authors:  E L Baldwin; N Osheroff
Journal:  Curr Med Chem Anticancer Agents       Date:  2005-07

6.  The structure of DNA-bound human topoisomerase II alpha: conformational mechanisms for coordinating inter-subunit interactions with DNA cleavage.

Authors:  Timothy J Wendorff; Bryan H Schmidt; Pauline Heslop; Caroline A Austin; James M Berger
Journal:  J Mol Biol       Date:  2012-07-25       Impact factor: 5.469

7.  Different patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development.

Authors:  G Capranico; S Tinelli; C A Austin; M L Fisher; F Zunino
Journal:  Biochim Biophys Acta       Date:  1992-08-17

8.  Plk1-dependent phosphorylation regulates functions of DNA topoisomerase IIalpha in cell cycle progression.

Authors:  Hongchang Li; Yun Wang; Xiaoqi Liu
Journal:  J Biol Chem       Date:  2008-01-02       Impact factor: 5.157

9.  Structural basis for recognition of 5'-phosphotyrosine adducts by Tdp2.

Authors:  Ke Shi; Kayo Kurahashi; Rui Gao; Susan E Tsutakawa; John A Tainer; Yves Pommier; Hideki Aihara
Journal:  Nat Struct Mol Biol       Date:  2012-10-28       Impact factor: 15.369

10.  Confirming TDP2 mutation in spinocerebellar ataxia autosomal recessive 23 (SCAR23).

Authors:  Guido Zagnoli-Vieira; Francesco Bruni; Kyle Thompson; Langping He; Sarah Walker; Arjan P M de Brouwer; Robert W Taylor; Dmitriy Niyazov; Keith W Caldecott
Journal:  Neurol Genet       Date:  2018-08-01
View more
  14 in total

Review 1.  DNA-protein crosslink formation by endogenous aldehydes and AP sites.

Authors:  Jun Nakamura; Mai Nakamura
Journal:  DNA Repair (Amst)       Date:  2020-02-10

2.  TOP2A inhibition reverses drug resistance of hepatocellular carcinoma to regorafenib.

Authors:  Zongwen Wang; Qiankun Zhu; Xiaodong Li; Xiaohang Ren; Jingtao Li; Yao Zhang; Shicong Zeng; Lishan Xu; Xiaoqun Dong; Bo Zhai
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

Review 3.  Excision repair of topoisomerase DNA-protein crosslinks (TOP-DPC).

Authors:  Yilun Sun; Sourav Saha; Wenjie Wang; Liton Kumar Saha; Shar-Yin Naomi Huang; Yves Pommier
Journal:  DNA Repair (Amst)       Date:  2020-03-07

4.  UPF1 promotes chemoresistance to oxaliplatin through regulation of TOP2A activity and maintenance of stemness in colorectal cancer.

Authors:  Congcong Zhu; Long Zhang; Senlin Zhao; Weixing Dai; Yun Xu; Yuqin Zhang; Hongtu Zheng; Weiqi Sheng; Ye Xu
Journal:  Cell Death Dis       Date:  2021-05-21       Impact factor: 8.469

5.  Replication and transcription machinery for ranaviruses: components, correlation, and functional architecture.

Authors:  Fei Ke; Xue-Dong Yu; Zi-Hao Wang; Jian-Fang Gui; Qi-Ya Zhang
Journal:  Cell Biosci       Date:  2022-01-06       Impact factor: 7.133

Review 6.  Human topoisomerases and their roles in genome stability and organization.

Authors:  Yves Pommier; André Nussenzweig; Shunichi Takeda; Caroline Austin
Journal:  Nat Rev Mol Cell Biol       Date:  2022-02-28       Impact factor: 113.915

Review 7.  The Safe Path at the Fork: Ensuring Replication-Associated DNA Double-Strand Breaks are Repaired by Homologous Recombination.

Authors:  Jac A Nickoloff; Neelam Sharma; Lynn Taylor; Sage J Allen; Robert Hromas
Journal:  Front Genet       Date:  2021-09-27       Impact factor: 4.772

8.  Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia.

Authors:  Koichi Oshima; Junfei Zhao; Pablo Pérez-Durán; Jessie A Brown; Juan Angel Patiño-Galindo; Timothy Chu; Aidan Quinn; Thomas Gunning; Laura Belver; Alberto Ambesi-Impiombato; Valeria Tosello; Zhengqiang Wang; Maria Luisa Sulis; Motohiro Kato; Katsuyoshi Koh; Maddalena Paganin; Giuseppe Basso; Milagros Balbin; Concepcion Nicolas; Julie M Gastier-Foster; Meenakshi Devidas; Mignon L Loh; Elisabeth Paietta; Martin S Tallman; Jacob M Rowe; Mark Litzow; Mark D Minden; Jules Meijerink; Raul Rabadan; Adolfo Ferrando
Journal:  Nat Cancer       Date:  2020-10-19

9.  Identification of Hub Genes in Anaplastic Thyroid Carcinoma: Evidence From Bioinformatics Analysis.

Authors:  Liqi Li; Mingjie Zhu; Hu Huang; Junqiang Wu; Dong Meng
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

10.  Substituted 4,5'-Bithiazoles as Catalytic Inhibitors of Human DNA Topoisomerase IIα.

Authors:  Kaja Bergant Loboda; Matej Janežič; Martina Štampar; Bojana Žegura; Metka Filipič; Andrej Perdih
Journal:  J Chem Inf Model       Date:  2020-06-22       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.